A clinical trial involving vasopressin, titled "Water Deprivation Protocol," was updated on August 28, 2026. The trial, registered as NCT01224704, is listed with a status of completed. The study phase is listed as not applicable. This update reflects a change in the trial's recorded status on ClinicalTrials.gov as of the date noted. No results, outcomes, or findings were included in this status update. The trial record does not specify additional details beyond the completed status and the date reported. Vasopressin remains an approved compound. Readers interested in the background and approved uses of vasopressin can consult the compound overview for further context.
Vasopressin Trial "Water Deprivation Protocol" Marked Completed
See the full vasopressin overview
Source: https://clinicaltrials.gov/study/NCT01224704